Skip to main content

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Medtronic

(

MDT

) pushed the Health Services industry lower today making it today's featured Health Services laggard. The industry as a whole closed the day down 0.3%. By the end of trading, Medtronic fell $0.59 (-1.0%) to $57.17 on average volume. Throughout the day, 3,532,076 shares of Medtronic exchanged hands as compared to its average daily volume of 3,830,400 shares. The stock ranged in price between $57.09-$57.60 after having opened the day at $57.43 as compared to the previous trading day's close of $57.76. Other companies within the Health Services industry that declined today were:

Bio-Reference Labs

(

BRLI

), down 6.6%,

Bovie Medical Corporation

(

BVX

), down 5.3%,

Arrhythmia Research Technology

(

HRT

TheStreet Recommends

), down 5.1% and

NeuroMetrix

(

NURO

), down 5.1%.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. The company operates in two segments, Cardiac and Vascular Group, and Restorative Therapies Group. Medtronic has a market cap of $56.5 billion and is part of the health care sector. The company has a P/E ratio of 15.1, below the S&P 500 P/E ratio of 17.7. Shares are up 40.8% year to date as of the close of trading on Wednesday. Currently there are 6 analysts that rate Medtronic a buy, no analysts rate it a sell, and 13 rate it a hold.

TheStreet Ratings rates

Medtronic

as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance, impressive record of earnings per share growth, increase in net income and notable return on equity. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.

On the positive front,

American Shared Hospital Services

(

AMS

), up 12.3%,

AcelRx Pharmaceuticals

(

ACRX

), up 10.3%,

IsoRay

(

ISR

), up 9.8% and

Synergetics USA

(

SURG

), up 8.8% , were all gainers within the health services industry with

Thermo Fisher Scientific

(

TMO

) being today's featured health services industry leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider

Health Care Select Sector SPDR

(

XLV

) while those bearish on the health services industry could consider

ProShares Ultra Short Health Care

(

RXD

).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.